These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1181 related articles for article (PubMed ID: 25404125)

  • 21. Effects of dalcetrapib in patients with a recent acute coronary syndrome.
    Schwartz GG; Olsson AG; Abt M; Ballantyne CM; Barter PJ; Brumm J; Chaitman BR; Holme IM; Kallend D; Leiter LA; Leitersdorf E; McMurray JJ; Mundl H; Nicholls SJ; Shah PK; Tardif JC; Wright RS;
    N Engl J Med; 2012 Nov; 367(22):2089-99. PubMed ID: 23126252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events.
    Riggs KA; Joshi PH; Khera A; Singh K; Akinmolayemi O; Ayers CR; Rohatgi A
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
    Wu F; Juonala M; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Burns TL; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Magnussen CG
    Circulation; 2024 Jan; 149(3):217-226. PubMed ID: 38014550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
    Skaaby T
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The macrophage and its related cholesterol efflux as a HDL function index in atherosclerosis.
    Yamamoto S; Narita I; Kotani K
    Clin Chim Acta; 2016 Jun; 457():117-22. PubMed ID: 27087419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque.
    Shea S; Stein JH; Jorgensen NW; McClelland RL; Tascau L; Shrager S; Heinecke JW; Yvan-Charvet L; Tall AR
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):89-96. PubMed ID: 30580560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.
    Mahajan N; Ference BA; Arora N; Madhavan R; Bhattacharya P; Sudhakar R; Sagar A; Wang Y; Sacks F; Afonso L
    Am J Cardiol; 2012 Jun; 109(12):1694-9. PubMed ID: 22465317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
    Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms associated with cholesterol and risk of cardiovascular events.
    Kathiresan S; Melander O; Anevski D; Guiducci C; Burtt NP; Roos C; Hirschhorn JN; Berglund G; Hedblad B; Groop L; Altshuler DM; Newton-Cheh C; Orho-Melander M
    N Engl J Med; 2008 Mar; 358(12):1240-9. PubMed ID: 18354102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.
    Hafiane A; Favari E; Daskalopoulou SS; Vuilleumier N; Frias MA
    Metabolism; 2020 Mar; 104():154141. PubMed ID: 31923386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
    Tuteja S; Rader DJ
    Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD.
    Ganda A; Yvan-Charvet L; Zhang Y; Lai EJ; Regunathan-Shenk R; Hussain FN; Avasare R; Chakraborty B; Febus AJ; Vernocchi L; Lantigua R; Wang Y; Shi X; Hsieh J; Murphy AJ; Wang N; Bijl N; Gordon KM; de Miguel MH; Singer JR; Hogan J; Cremers S; Magnusson M; Melander O; Gerszten RE; Tall AR
    J Mol Cell Cardiol; 2017 Nov; 112():114-122. PubMed ID: 28478047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
    Suk Danik J; Rifai N; Buring JE; Ridker PM
    JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
    Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology.
    Doonan RJ; Hafiane A; Lai C; Veinot JP; Genest J; Daskalopoulou SS
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):921-6. PubMed ID: 24558111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time dependent changes in high density lipoprotein cholesterol and cardiovascular risk.
    Milwidsky A; Kivity S; Kopel E; Klempfner R; Berkovitch A; Segev S; Sidi Y; Goldenberg I; Maor E
    Int J Cardiol; 2014 May; 173(2):295-9. PubMed ID: 24681020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
    Bansal S; Buring JE; Rifai N; Mora S; Sacks FM; Ridker PM
    JAMA; 2007 Jul; 298(3):309-16. PubMed ID: 17635891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.